ALPHA BETA TECHNOLOGY has a total of 59 patent applications. Its first patent ever was published in 1988. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, macromolecular chemistry and polymers and machines are MARUHA CORP, MCW RES FOUNDATION and GRAUPNER GERHART.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 16 | |
#2 | WIPO (World Intellectual Property Organization) | 10 | |
#3 | Australia | 9 | |
#4 | Canada | 6 | |
#5 | EPO (European Patent Office) | 5 | |
#6 | Japan | 3 | |
#7 | Brazil | 1 | |
#8 | Finland | 1 | |
#9 | Hungary | 1 | |
#10 | Ireland | 1 | |
#11 | Israel | 1 | |
#12 | Mexico | 1 | |
#13 | Norway | 1 | |
#14 | New Zealand | 1 | |
#15 | Poland | 1 | |
#16 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Macromolecular chemistry and polymers | |
#3 | Machines | |
#4 | Biotechnology | |
#5 | Environmental technology | |
#6 | Measurement | |
#7 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Polysaccharides | |
#4 | Unspecified technologies | |
#5 | Climate change adaptation technologies | |
#6 | Fermentation | |
#7 | Foods | |
#8 | Analysing materials | |
#9 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Ostroff Gary R | 43 |
#2 | Jamas Spiros | 43 |
#3 | Easson D Davidson Jr | 27 |
#4 | Easson Jr D Davidson | 11 |
#5 | Bistrian Bruce R | 6 |
#6 | Mackin William M | 5 |
#7 | Wakshull Eric M | 4 |
#8 | Wakshull Eric | 3 |
#9 | Zimmermann Janet | 3 |
#10 | Stevenson Thomas T | 2 |
Publication | Filing date | Title |
---|---|---|
WO9966878A2 | Use of bis(diazo) compound as antifungal agents | |
WO9931504A1 | ACTIVATION OF TRANSCRIPTION FACTOR COMPLEX BY β(1-3) GLUCAN | |
US5811542A | Method for producing soluble glucans | |
CA2140220A1 | Inhibition of infection-stimulated oral tissue destruction by .beta.(1,3)-glucan | |
WO9512620A1 | Derivatized polysaccharide bile acid sequestrant for reducing cholesterol | |
JPH0827009A | Beta-(1,3)-glucan used for suppressing destroy of oral cavity tissue caused by infectious irritation | |
US5622940A | Inhibition of infection-stimulated oral tissue destruction by β(1,3)-glucan | |
CA2142811A1 | Novel glucan preparation | |
US5488040A | Use of neutral soluble glucan preparations to stimulate platelet production | |
US5622939A | Glucan preparation | |
EP0490995A1 | Method for producing soluble glucans | |
EP0491829A1 | Composition for immune system activation | |
US5032401A | Glucan drug delivery system and adjuvant | |
US4962094A | Glucan dietary additives |